Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-004985
Filing Date
2025-07-14
Accepted
2025-07-14 16:03:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 9787
  Complete submission text file 0001950047-25-004985.txt   11230
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36033 | Film No.: 251121770
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
Farnum Rhonda (Reporting) CIK: 0001898490 (see all company filings)

Type: 144